Influenza Archives - PharmaDeviceNews

ArkBio pushes AK0406 into first-in-human testing, but can a long-acting flu antiviral carve out real clinical space?

By Pallavi Madhiraju on April 10, 2026 Pharma & Biotech

ArkBio has begun Phase I testing of AK0406 in Australia. Read why this long-acting influenza candidate matters and what risks still need proving.

Why FDA’s clearance of ACON’s Flowflex Plus test marks a turning point in home diagnostics

By Pallavi Madhiraju on January 24, 2026 Medical Devices & Diagnostics

FDA clears Flowflex Plus 4-in-1 test for RSV, flu, and COVID in infants and adults. Find out what this means for diagnostics, families, and industry players.

Hyundai Bioscience begins U.S. Phase 2 trial of Xafty for COVID, flu, and RSV

By Pallavi Madhiraju on January 15, 2026 Pharma & Biotech

Hyundai Bioscience enters U.S. Phase 2 trials for Xafty, a broad-spectrum antiviral targeting flu, RSV, and COVID. Find out what this means for future pandemics.